COMPARISON OF 2 OTITIS-MEDIA MODELS FOR THE STUDY OF MIDDLE-EAR ANTIMICROBIAL PHARMACOKINETICS

被引:4
作者
CANAFAX, DM
RUSSLIE, H
LOVDAHL, MJ
ERDMANN, GR
LE, CT
GIEBINK, GS
机构
[1] UNIV MINNESOTA,COLL PHARM,DEPT PHARM PRACTICE,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA,COLL PHARM,DEPT OTOLARYNGOL,MINNEAPOLIS,MN 55455
[3] UNIV MINNESOTA,COLL PHARM,DEPT SURG,MINNEAPOLIS,MN 55455
[4] UNIV MINNESOTA,COLL PHARM,DEPT BIOSTAT,MINNEAPOLIS,MN 55455
[5] UNIV MINNESOTA,COLL PHARM,DEPT PEDIAT,MINNEAPOLIS,MN 55455
[6] UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455
关键词
OTITIS MEDIA; PHARMACOKINETICS; AMOXICILLIN; SULFAMETHOXAZOLE; TRIMETHOPRIM;
D O I
10.1023/A:1018981808868
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We compared two models of acute otitis media that estimate middle ear antimicrobial pharmacokinetics. Using a crossover study design, we compared a systemic drug administration model with a diffusion model we devised that measures the disappearance of antimicrobials from the middle ear. We induced acute otitis media in 14 chinchillas by inoculating S. pneumoniae into the middle ear, then administered 3 antimicrobials: amoxicillin, trimethoprim, and sulfamethoxazole. Next we collected middle ear fluid samples to analyze drug concentrations and compare rate constants for the systemic and diffusion models by analysis of variance. We found that amoxicillin K values were not affected by model testing sequence (p = 0.827) or model type (systemic versus diffusion, p = 0.310), nor were sulfamethoxazole K values: model testing sequence (p = 0.917), model type (p = 0.963). Trimethoprim K values were also not affected by model testing sequence (p = 0/1760), but were by model type (p = 0.0001). Trimethoprim elimination from the diffusion model was faster(K = 0.33 +/- 0.17 versus 0.57 +/- 0.09 hr-1) than from the systemic model, although it appears this was caused by sampling before drug distribution into the middle ear was complete. In conclusion, it appears K values derived from either systemic antimicrobial administration or direct middle ear instillation are similar for assessing middle ear anitmicrobial pharmacokinetics, and these models can be used interchangeably to study factors affecting otitis media treatment response.
引用
收藏
页码:855 / 859
页数:5
相关论文
共 10 条
[1]  
CANAFAX DM, 1991, OTOLARYNG CLIN N AM, V24, P859
[2]   EXPERIMENTAL ANIMAL-MODELS FOR STUDYING ANTIMICROBIAL PHARMACOKINETICS IN OTITIS-MEDIA [J].
CANAFAX, DM ;
NONOMURA, N ;
ERDMANN, GR ;
LE, CT ;
JUHN, SK ;
GIEBINK, GS .
PHARMACEUTICAL RESEARCH, 1989, 6 (04) :279-285
[3]   MICROCOMPUTER BASED PHARMACOKINETIC PROGRAMS FOR CALCULATING ABSORPTION RATE [J].
CHAN, KKH ;
WNUCK, K .
COMPUTER PROGRAMS IN BIOMEDICINE, 1983, 16 (1-2) :27-33
[4]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF AMOXICILLIN IN MICROLITER VOLUMES OF CHINCHILLA MIDDLE-EAR EFFUSION AND PLASMA [J].
ERDMANN, GR ;
WALKER, K ;
GIEBINK, GS ;
CANAFAX, DM .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1990, 13 (16) :3339-3350
[5]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF TRIMETHOPRIM AND SULFAMETHOXAZOLE IN MICROLITER VOLUMES OF CHINCHILLA MIDDLE-EAR EFFUSION AND SERUM [J].
ERDMANN, GR ;
CANAFAX, DM ;
GIEBINK, GS .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1988, 433 :187-195
[6]   ANTIMICROBIAL TREATMENT OF ACUTE OTITIS-MEDIA [J].
GIEBINK, GS ;
CANAFAX, DM ;
KEMPTHORNE, J .
JOURNAL OF PEDIATRICS, 1991, 119 (03) :495-500
[7]  
GIEBINK GS, 1986, EXPT MODELS ANTIMICR, V1, P213
[8]   EFFECT OF STREPTOCOCCUS-PNEUMONIAE AND INFLUENZA-A VIRUS ON MIDDLE-EAR ANTIMICROBIAL PHARMACOKINETICS IN EXPERIMENTAL OTITIS-MEDIA [J].
JOSSART, GH ;
CANAFAX, DM ;
ERDMANN, GR ;
LOVDAHL, MJ ;
RUSSLIE, HQ ;
JUHN, SK ;
GIEBINK, GS .
PHARMACEUTICAL RESEARCH, 1994, 11 (06) :860-864
[9]   AN EXPERIMENTAL-MODEL FOR MEASURING MIDDLE-EAR ANTIMICROBIAL DRUG PENETRATION IN OTITIS-MEDIA [J].
JOSSART, GH ;
ERDMANN, GR ;
LEVITT, DG ;
KUCERA, P ;
LE, CT ;
JUHN, SK ;
GIEBINK, GS ;
CANAFAX, DM .
PHARMACEUTICAL RESEARCH, 1990, 7 (12) :1242-1247
[10]   AN INVITRO PHARMACODYNAMIC MODEL TO SIMULATE ANTIBIOTIC BEHAVIOR OF ACUTE OTITIS-MEDIA WITH EFFUSION [J].
VANCEBRYAN, K ;
LARSON, TA ;
GARRISON, MW ;
TOSCANO, JP ;
CANAFAX, DM ;
ROTSCHAFER, JC .
PHARMACEUTICAL RESEARCH, 1992, 9 (07) :920-924